GPAT

Company Overview — What Does GP-Act III Acquisition Corp. Do?

We are a blank check company incorporated as a Cayman Islands exempted company whose business purpose is to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. We have generated no revenues to date and we do not expect that we will generate operating revenues at the earliest until we consummate our initial business combination. Our efforts to identify a prospective initial business combination target will not be limited to a particular industry, sector or geographic region. While we may pursue an initial business combination opportunity in any industry or sector, we intend to capitalize on the ability of our management team to identify, acquire and operate a business or businesses that can benefit from our management team’s established global relationships, sector expertise and active management and operating experience. Our co-sponsor, GPIAC II, LLC, is a wholly-owned subsidiary of GP Investments, a leading private equity and alternative investment firm with over 30 years of history assisting companies to develop, grow and build long lasting capabilities through operational and governance improvements. Since its founding in 1993, GP Investments has completed over 50 private equity investments, has executed over 30 equity capital market transactions and has raised more than $5.0 billion through eight funds. Additionally, GP Investments has invested over $1.0 billion of proprietary capital alongside investors. GP Investments has made investments across numerous sectors, building a strong track record in the consumer, business services, industrial and technology sectors in particular, leading business transformations that have created market leaders in all of these segments. Through such investments, the firm has provided companies not only with capital to fuel growth but also with active managerial support as they developed their strategies to embrace digital transformation and adapt to other market shifts or navigated pivotal events when seeking access to equity capital markets, or implementing mergers and acquisitions. Throughout the years, numerous professionals that grew within the GP Investments’ ecosystem went on to serve in leadership roles in some of the largest companies in the world, such as AB InBev, Kraft Heinz, Restaurant Brands International, Google, Uber, and --- Our co-sponsor, IDS III LLC, is led by Mr. Irwin Simon. Mr. Simon brings a wealth of experience in leading and scaling multi-billion-dollar companies in multiple sectors. Mr. Simon currently serves as the Chairman and CEO of Tilray (NASDAQ:TLRY), a global leader in cannabis research and production, and has previously founded and acted as the Chairman and CEO of Hain Celestial Group (NASDAQ:HAIN), growing the business into a leading organic and natural products company in North America, Europe, Asia, and the Middle East. Mr. Simon has more than 30 years of business experience spanning many domestic and international leadership and operating roles. During his career, Mr. Simon has executed over 60 deals worth approximately $7.5 billion (net of divestitures) including Aphria’s business combination with Tilray that is described below. Mr. Simon currently serves as Executive Chairman of Whole Earth Brands, which is a result of Act II Global Acquisition Corp.’s business combination, a position he has held since June 2020, when the business combination with Act II was completed, and serves as Lead Director at Stagwell Inc. (NASDAQ:STGW). Mr. Simon also serves on the board of directors at Tulane University and the Board of Trustees at Poly Prep Country Day School. Mr. Simon founded The Hain Celestial Group, Inc. (NASDAQ: HAIN), or Hain Celestial, in 1993, with a mission to be the leading marketer, manufacturer and seller of organic and natural, better-for-you products, committed to growing sustainably while continuing to implement environmentally sound business practices and manufacturing processes. Mr. Simon led Hain Celestial for more than 25 years and grew the business to approximately $3.5 billion in net sales with operations in North America, Europe, Asia and the Middle East, and served as Founder, President, Chief Executive Officer and Chairman through 2018. --- Our co-sponsor, Boxcar Partners III, LLC, is led by Mr. Steven Spinner. Mr. Spinner brings a wealth of experience in leading and scaling multi-billion-dollar companies in multiple sectors. Mr. Spinner, in the capacity of CEO and Chairman of United Natural Foods (NYSE: UNFI), has shaped the distribution landscape for natural, organic, and specialty foods, successfully leading United Natural Foods through major acquisitions and expansion initiatives. We are a Cayman Islands exempted company incorporated on November 23, 2020. Our executive offices are located at 300 Park Avenue, 2nd Floor, New York, NY. GP-Act III Acquisition Corp. (GPAT) is classified as a small-cap stock in the Financials sector, specifically within the Trading industry. The company is led by CEO Antonio Bonchristiano. With a market capitalization of $389M, GPAT is one of the notable companies in the Financials sector.

GP-Act III Acquisition Corp. (GPAT) Stock Rating — Hold (April 2026)

As of April 2026, GP-Act III Acquisition Corp. receives a Hold rating with a composite score of 36.1/100 and 3 out of 5 stars from the Blank Capital Research quantitative model.GPAT ranks #1,029 out of 4,446 stocks in our coverage universe. Within the Financials sector, GP-Act III Acquisition Corp. ranks #335 of 900 stocks, placing it in the upper half of its Financials peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).

GPAT Stock Price and 52-Week Range

GP-Act III Acquisition Corp. (GPAT) currently trades at $10.88. The 52-week high for GPAT is $10.81, which means the stock is currently trading 0.6% from its annual peak. The 52-week low is $10.27, putting the stock 5.9% above its annual trough. Recent trading volume was 0 shares, suggesting relatively thin trading activity.

Is GPAT Overvalued or Undervalued? — Valuation Analysis

GP-Act III Acquisition Corp. (GPAT) carries a value factor score of 40/100 in the Blank Capital model, indicating fair valuation relative to historical norms. The trailing price-to-earnings ratio is 30.78x, compared to the Financials sector average of 14.78x — a premium of 108%.

Overall, GPAT's valuation appears roughly in line with sector benchmarks, suggesting the market is pricing the stock fairly given its current fundamentals and growth trajectory. Neither deep value nor significantly overpriced, the stock occupies a middle ground on valuation.

GP-Act III Acquisition Corp. Profitability — ROE, Margins, and Quality Score

GP-Act III Acquisition Corp. (GPAT) earns a quality factor score of 10/100, signaling below-average profitability metrics relative to the broader market. The return on equity (ROE) is 4.3%, compared to the Financials sector average of 8.5%, which is below typical expectations for high-quality companies. Return on assets (ROA) comes in at 4.1% versus the sector average of 1.3%.

Profitability is below benchmark levels, which may reflect industry headwinds, elevated reinvestment, or structural challenges.

GPAT Debt, Balance Sheet, and Financial Health

GP-Act III Acquisition Corp. has a debt-to-equity ratio of 0.0%, compared to the Financials sector average of 118.5%. The low leverage indicates a conservative balance sheet with significant financial flexibility. The current ratio is 0.30x, which may signal near-term liquidity tightness.

GPAT has a beta of 0.01, meaning it is less volatile than the S&P 500, making it a relatively defensive holding. The stability factor score for GP-Act III Acquisition Corp. is 98/100, indicating low-volatility characteristics and consistent price behavior that appeals to risk-averse investors.

GP-Act III Acquisition Corp. Revenue and Earnings History — Quarterly Trend

In TTM 2026, GP-Act III Acquisition Corp. reported revenue of $0. Net income for the quarter was $13M. Operating income came in at $-611,176.

In FY 2025, GP-Act III Acquisition Corp. reported revenue of N/A. Net income for the quarter was $12M. Operating income came in at $-551,918.

In Q3 2025, GP-Act III Acquisition Corp. reported revenue of N/A. Net income for the quarter was $3M. Operating income came in at $-126,328.

In Q2 2025, GP-Act III Acquisition Corp. reported revenue of $0 and earnings per share (EPS) of $0.00. Net income for the quarter was $3M. Operating income came in at $-141,334.

Over the past 8 quarters, GP-Act III Acquisition Corp. has experienced revenue contraction from $0 to $0. Investors analyzing GPAT stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.

GPAT Dividend Yield and Income Analysis

GP-Act III Acquisition Corp. (GPAT) does not currently pay a dividend. This is common among smaller companies in the Trading industry that prefer to reinvest cash flows into business expansion rather than returning capital to shareholders. Income-focused investors looking for Financials dividend stocks may want to explore other Financials stocks or use the stock screener to filter by dividend yield.

GPAT Momentum and Technical Analysis Profile

GP-Act III Acquisition Corp. (GPAT) has a momentum factor score of 40/100, reflecting neutral trend characteristics. The stock is neither significantly outperforming nor underperforming the broader market on a momentum basis. The investment factor score is 25/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 48/100 reflects moderate short selling activity.

GPAT vs Competitors — Financials Sector Ranking and Peer Comparison

Within the Financials sector, GP-Act III Acquisition Corp. (GPAT) ranks #335 out of 900 stocks based on the Blank Capital composite score. This places GPAT in the upper half of all Financials stocks in our coverage universe. Key competitors and sector peers include UNIVERSAL INSURANCE HOLDINGS, INC. (UVE) with a score of 62.6/100, WHITE MOUNTAINS INSURANCE GROUP LTD (WTM) with a score of 63.3/100, PARKE BANCORP, INC. (PKBK) with a score of 60.5/100, OPPENHEIMER HOLDINGS INC (OPY) with a score of 62.3/100, and PEOPLES BANCORP OF NORTH CAROLINA INC (PEBK) with a score of 57.6/100.

Comparing GPAT against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full GPAT vs S&P 500 (SPY) comparison to assess how GP-Act III Acquisition Corp. stacks up against the broader market across all factor dimensions.

GPAT Next Earnings Date

No upcoming earnings date has been announced for GP-Act III Acquisition Corp. (GPAT) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.

Should You Buy GPAT? — Investment Thesis Summary

GP-Act III Acquisition Corp. presents a balanced picture with arguments on both sides. The quality score of 10/100 flags below-average profitability. Low volatility (stability score 98/100) reduces downside risk.

In summary, GP-Act III Acquisition Corp. (GPAT) earns a Hold rating with a composite score of 36.1/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on GPAT stock.

Related Resources for GPAT Investors

Explore more research and tools: GPAT vs S&P 500 comparison, top Financials stocks, stock screener, our methodology, quality factor explained, value factor explained, momentum factor explained. Compare GPAT head-to-head with peers: GPAT vs UVE, GPAT vs WTM, GPAT vs PKBK.